Author

Fucong Xie

University of North Carolina at Chapel Hill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alexander N. JamboriD· 1 shared Andrew S. KennedyiD· 1 shared Ashwin SomasundaramiD· 1 shared Brandon M. PrattiD· 1 shared Coral del Mar Alicea Pauneto· 1 shared Emily F. MerrittiD· 1 shared Gabrielle Heather CannoniD· 1 shared Genevieve Nicole MullinsiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexander N. JamborORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Latent Regulatory Programs Generate Synthetic T Cell States with Enhanced Therapeutic Potential

Brandon M. Pratt, Genevieve Nicole Mullins, Nolan James Brown, William D. Green, Jennifer L. Modliszewski, Fucong Xie, Lara van Rooyen, Vasyl Zhabotynsky, Alexander N. Jambor, Gabrielle Heather Cannon, Jarred Michael Green, Andrew S. Kennedy, Coral del Mar Alicea Pauneto, Huitong Shi, Emily F. Merritt, , J. Justin Milner

The paper uses in vivo single-cell gain-of-function screening to identify latent transcriptional programs that reprogram T cells into synthetic states with enhanced therapeutic potential.

bioRxiv · Jan 8, 2026 · PreprintImmunology